174 related articles for article (PubMed ID: 15950299)
1. Levosimendan reduces plasma amino terminal proBNP in patients with decompensated heart failure.
Mueller T; Gegenhuber A; Haltmayer M
Int J Cardiol; 2005 Oct; 104(3):355-6; author reply 357-8. PubMed ID: 15950299
[No Abstract] [Full Text] [Related]
2. Levosimendan therapy in decompensated chronic heart failure: favourable haemodynamic and neurohormonal effects but for how long?
Parissis JT; Farmakis D; Kremastinos DT
Eur J Heart Fail; 2006 Mar; 8(2):215; author reply 218. PubMed ID: 16442844
[No Abstract] [Full Text] [Related]
3. Effects of levosimendan versus dobutamine on inflammatory and apoptotic pathways in acutely decompensated chronic heart failure.
Adamopoulos S; Parissis JT; Iliodromitis EK; Paraskevaidis I; Tsiapras D; Farmakis D; Karatzas D; Gheorghiade M; Filippatos GS; Kremastinos DT
Am J Cardiol; 2006 Jul; 98(1):102-6. PubMed ID: 16784930
[TBL] [Abstract][Full Text] [Related]
4. Oral levosimendan in patients with severe chronic heart failure --the PERSIST study.
Nieminen MS; Cleland JG; Eha J; Belenkov Y; Kivikko M; Põder P; Sarapohja T
Eur J Heart Fail; 2008 Dec; 10(12):1246-54. PubMed ID: 18945637
[TBL] [Abstract][Full Text] [Related]
5. [Effect of levosimendan on B-type natriuretic peptide levels in patients with advanced heart failure: a meta-analysis].
Xu ZD; He WX; Zhao YF; Xia SX; He B; Yang T; Cao DX; Peng SL; Li J; Cao MH
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Oct; 29(10):2027-9. PubMed ID: 19861257
[TBL] [Abstract][Full Text] [Related]
6. The prolonged lowering effect of levosimendan on brain natriuretic peptide levels in patients with decompansated heart failure: clinical implications.
Celik T; Iyisoy A; Yuksel UC; Kardesoglu E
Int J Cardiol; 2008 Aug; 128(1):97-9; authr reply 100-2. PubMed ID: 18501448
[TBL] [Abstract][Full Text] [Related]
7. Natriuretic peptide-guided levosimendan therapy for heart failure: a promising new approach.
Giamouzis G; Giannakoulas G; Tsarpalis K; Agha SA; Georgiopoulou V; Kalogeropoulos A; Karvounis H; Butler J
Int J Cardiol; 2008 Aug; 128(1):91-3; author reply 94-6. PubMed ID: 18495268
[No Abstract] [Full Text] [Related]
8. Assessment of sustained effects of levosimendan and dobutamine on left ventricular systolic functions by using novel tissue Doppler derived indices in patients with advanced heart failure.
Oner E; Erturk M; Birant A; Kurtar Mansıroglu A; Akturk IF; Karakurt H; Yalcin AA; Uzun F; Somuncu MU; Yildirim A
Cardiol J; 2015; 22(1):87-93. PubMed ID: 24846511
[TBL] [Abstract][Full Text] [Related]
9. Duration of the haemodynamic action of a 24-h infusion of levosimendan in patients with congestive heart failure.
Lilleberg J; Laine M; Palkama T; Kivikko M; Pohjanjousi P; Kupari M
Eur J Heart Fail; 2007 Jan; 9(1):75-82. PubMed ID: 16829185
[TBL] [Abstract][Full Text] [Related]
10. Levosimendan reduces plasma B-type natriuretic peptide and interleukin 6, and improves central hemodynamics in severe heart failure patients.
Kyrzopoulos S; Adamopoulos S; Parissis JT; Rassias J; Kostakis G; Iliodromitis E; Degiannis D; Kremastinos DT
Int J Cardiol; 2005 Mar; 99(3):409-13. PubMed ID: 15771921
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of acute neurohormonal response after levosimendan treatment.
Giannakoulas G; Giannoglou G; Vassilikos V; Martiadou K; Kalpidis P; Parharidis G; Louridas G
Am J Cardiol; 2006 Oct; 98(8):1123-4. PubMed ID: 17027590
[No Abstract] [Full Text] [Related]
12. Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial.
Mebazaa A; Nieminen MS; Packer M; Cohen-Solal A; Kleber FX; Pocock SJ; Thakkar R; Padley RJ; Põder P; Kivikko M;
JAMA; 2007 May; 297(17):1883-91. PubMed ID: 17473298
[TBL] [Abstract][Full Text] [Related]
13. Effects of levosimendan on markers of left ventricular diastolic function and neurohormonal activation in patients with advanced heart failure.
Parissis JT; Panou F; Farmakis D; Adamopoulos S; Filippatos G; Paraskevaidis I; Venetsanou K; Lekakis J; Kremastinos DT
Am J Cardiol; 2005 Aug; 96(3):423-6. PubMed ID: 16054474
[TBL] [Abstract][Full Text] [Related]
14. Plasma B-type natriuretic peptide reduction predicts long-term response to levosimendan therapy in acutely decompensated chronic heart failure.
Farmakis D; Parissis JT; Bistola V; Paraskevaidis IA; Iliodromitis EK; Filippatos G; Kremastinos DT
Int J Cardiol; 2010 Feb; 139(1):75-9. PubMed ID: 18973957
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of dobutamine-induced changes of the two-dimensional longitudinal deformation predict clinical and neurohumoral improvement in men after levosimendan treatment in acutely decompensated chronic heart failure.
Paraskevaidis IA; Bistola V; Ikonomidis I; Parissis JT; Papadopoulos C; Filippatos G; Kremastinos DT
Am J Cardiol; 2008 Nov; 102(9):1225-9. PubMed ID: 18940297
[TBL] [Abstract][Full Text] [Related]
16. A struggle to SURVIVE: to abandon or not to abandon levosimendan?
Butler J; Giamouzis G; Giannakoulas G
Cardiovasc Drugs Ther; 2007 Oct; 21(5):401-2. PubMed ID: 17701453
[No Abstract] [Full Text] [Related]
17. Evaluation of the clinical, hemodynamic and neurohormonal response to levosimendan administration in decompensated heart failure patients. One-month follow-up.
Sargento L; Brito D; Matias JS; Madeira H
Rev Port Cardiol; 2007; 26(7-8):717-26. PubMed ID: 17939581
[TBL] [Abstract][Full Text] [Related]
18. Effects of levosimendan on TNF-alpha, BNP and MMP-1 in patients with heart failure with anemia.
Büyüklü M; Kürüm AT; Tatlý E; Set T
Arq Bras Cardiol; 2012 Jul; 99(1):659-64. PubMed ID: 22735864
[TBL] [Abstract][Full Text] [Related]
19. [Levosimendan for treatment of heart failure].
Yasumura Y
Nihon Rinsho; 2007 May; 65 Suppl 5():169-72. PubMed ID: 17571380
[No Abstract] [Full Text] [Related]
20. Effects of levosimendan on circulating pro-inflammatory cytokines and soluble apoptosis mediators in patients with decompensated advanced heart failure.
Parissis JT; Adamopoulos S; Antoniades C; Kostakis G; Rigas A; Kyrzopoulos S; Iliodromitis E; Kremastinos D
Am J Cardiol; 2004 May; 93(10):1309-12. PubMed ID: 15135713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
